Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Technology Scientific & Technical Instruments
Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery... see more

Recent & Breaking News (CSE:SONA)

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study

Newsfile 13 days ago

Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development

Newsfile April 8, 2024

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results

Newsfile March 25, 2024

Sona Nanotech files patent application for photothermal light device

Jocelyn Aspa March 18, 2024

Sona Nanotech Announces Filing of Provisional Patent Application

Newsfile March 18, 2024

Sona Nanotech Grants Options

Newsfile March 1, 2024

Sona Nanotech Announces Director Retirement

Newsfile January 10, 2024

Sona Nanotech Closes Private Placement Financing to Raise $750,000 in Gross Proceeds and Announces Additional Financing

Newsfile November 27, 2023

Sona Nanotech Arranges Brokered Private Placement Financing

Newsfile October 18, 2023

Sona Provides Corporate Update on Operating Activities

Newsfile October 12, 2023

Unique cancer therapy to be assessed for efficacy in research study

Jonathon Brown September 11, 2023

Sona's 'THT' Cancer Therapy to be Assessed for Efficacy and Ability to Act as a Catalyst to Generate Immune Responses in Research Study

Newsfile September 11, 2023

Sona to Engage with Medical Experts and Payors to Inform Regulatory and Commercialization Strategies for Its 'THT' Cancer Therapy

Newsfile September 5, 2023

Sona Nanotech Grants Options

Newsfile July 11, 2023

New NCL Assessment of Sona's GNR Technology Highlights Process Improvement Success

Newsfile June 8, 2023

Sona Nanotech Selects Minnetronix to Engineer Its Next Generation Targeted Hyperthermia Cancer Therapy Light Device

Newsfile May 30, 2023

Sona Nanotech Elects New Board Chair and is Awarded Patent

Newsfile May 18, 2023

Sona Nanotech (CSE:SONA) sells its interest in the Legacy Crescent Lake Lithium Property

Jonathon Brown May 9, 2023

Sona's Interest in Legacy Crescent Lake Lithium Property Sold to Midex Resources

Newsfile May 9, 2023

Sona Nanotech (CSE:SONA) secures Bentley Biomedical

Brieanna McCutcheon  April 17, 2023